跳至主要内容
临床试验/JPRN-UMIN000029926
JPRN-UMIN000029926已完成2 期

The efficacy of Leukotriene receptor antagonist for human rectal aberrant crypt foci: nonrandomized open label controlled trial - The efficacy of LTRA for human ACF

Yokohama City University0 个研究点目标入组 40 人开始时间: 2017年11月13日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

TRA decreased rectal ACF

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with lesion which preferred early resection. 2.History of use of LTRA within 2months before trial entry. 3.History of malignant disease within 5 yeears before trial entry. 4.History of heart failure, renal failure, liver cirrhosis or chronic hepatic failure 5.History of familial adenomatous polyposis, hereditary non-polyposis colorectal cancer and inflammatory bowel disease 6.Pregnancy or possibility of pregnancy 7.Contraindication to Montelukast 8.Allergy to Montelukast 9.Regular use of NSAIDs, metformin, piogrlitazone 10.Patients judged as inappropriate candidates for the trial by the investigators

研究者

相似试验